BRIEF published on 03/19/2025 at 16:50, 10 months 15 days ago Bausch Health Initiates $4 Billion Senior Secured Notes Offering Bausch Health Senior Secured Notes Debt Restructuring Financial Offering Credit Facilities
PRESS RELEASE published on 03/19/2025 at 16:45, 10 months 15 days ago Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes Bausch Health Companies Inc. launches $4.0 billion offering of new senior secured notes due 2032 and plans to enter into new senior secured credit facilities Bausch Health Companies Inc. Financial News Senior Secured Notes Offering Credit Facilities
BRIEF published on 03/14/2025 at 14:30, 10 months 20 days ago Bausch Health Updates on Financing Plans with J.P. Morgan Market Conditions Bausch Health J.P. Morgan Financing Plans Securities Regulations
PRESS RELEASE published on 03/14/2025 at 14:25, 10 months 20 days ago Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan Bausch Health engages J.P. Morgan for financing plans update. Market conditions may impact transaction completion. Forward-looking statements cautionary Forward-looking Statements Market Conditions Bausch Health J.P. Morgan Financing Plans
BRIEF published on 02/19/2025 at 22:10, 11 months 11 days ago Bausch Health Reports Strong Financial Performance in 2024 Adjusted EBITDA Revenue Growth Financial Performance Bausch Health 2024 Results
PRESS RELEASE published on 02/19/2025 at 22:05, 11 months 11 days ago Bausch Health Announces Fourth Quarter and Full-Year 2024 Results Bausch Health Companies Inc. announces strong Q4 and full-year 2024 financial results, achieving revenue growth in all segments and exceeding adjusted EBITDA guidance Financial Results Adjusted EBITDA Revenue Growth Bausch Health Q4 2024
BRIEF published on 02/14/2025 at 14:05, 11 months 17 days ago Bausch Health to Attend J.P. Morgan Finance Conference Healthcare Pharmaceutical Webcast Bausch Health Finance Conference
PRESS RELEASE published on 02/14/2025 at 14:00, 11 months 17 days ago Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference Bausch Health Companies Inc. to participate in 2025 J.P. Morgan Global Leveraged Finance Conference on February 24. Webcast available on Investor Relations section of Bausch Health's website Investor Relations Webcast Conference Bausch Health J.P. Morgan
BRIEF published on 02/10/2025 at 14:05, 11 months 21 days ago Bausch Health Launches 2025 Salix GI Health Scholars Program Salix Pharmaceuticals Bausch Health Higher Education GI Diseases Scholarship Program
PRESS RELEASE published on 02/10/2025 at 14:00, 11 months 21 days ago Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program Bausch Health and Salix Pharmaceuticals launch 2025 Salix Gastrointestinal Health Scholars Program, offering scholarships for students living with GI diseases. Application deadline on May 5, 2025 Salix Pharmaceuticals Bausch Health Scholarships GI Diseases 2025
Published on 02/03/2026 at 15:00, 4 hours 50 minutes ago Vox Royalty Announces Record 2025 Annual and Quarterly Receipts and Exceeds Annual Guidance
Published on 02/03/2026 at 14:29, 5 hours 21 minutes ago Worksport Ltd. Announces Strategic Partnership With Potomac International Partners to Accelerate Federal Government and Commercial Market Adoption of Clean Energy Ecosystem
Published on 02/03/2026 at 13:58, 5 hours 52 minutes ago QNX and Haleytek Join Forces to Deliver Software-Defined Audio for Volvo Cars' EX60 EV SUV
Published on 02/03/2026 at 13:30, 6 hours 20 minutes ago Alset AI's Lyken.AI Secures Cloud Compute Services Purchase Order from Leading Multinational Technology and Telecommunications Company
Published on 02/03/2026 at 13:30, 6 hours 20 minutes ago Lahontan Selects RESPEC and Kappes Cassiday to Update Santa Fe Mineral Resource Estimate and PEA
Published on 02/03/2026 at 19:44, 5 minutes ago learnd Continues Growth Trajectory with Acquisition of Safe & Sound Control Systems
Published on 02/03/2026 at 19:38, 12 minutes ago EQS-Adhoc: ams-OSRAM AG: ams OSRAM sells non-optical analog/mixed-signal sensor business to Infineon for EUR 570 m in cash, reduces pro-forma leverage ratio to 2.5 and is creating the leader in Digital Photonics
Published on 02/03/2026 at 19:37, 13 minutes ago ams-OSRAM AG: ams OSRAM sells non-optical analog/mixed-signal sensor business to Infineon for EUR 570 m in cash, reduces pro-forma leverage ratio to 2.5 and is creating the leader in Digital Photonics
Published on 02/03/2026 at 19:06, 44 minutes ago Quarterly Activities Report for the period ending 31 December 2025
Published on 02/03/2026 at 18:39, 1 hour 11 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/03/2026 at 08:00, 11 hours 50 minutes ago EURAZEO & PANTHEON ESTABLISH A NEARLY €500 MILLION PRIVATE DEBT CONTINUATION VEHICLE
Published on 02/03/2026 at 08:00, 11 hours 50 minutes ago Neoen launches three new solar farms in France with a total capacity of 230 MWp
Published on 02/02/2026 at 18:23, 1 day 1 hour ago Monthly disclosure of the total number of shares and voting rights - January 2026
Published on 02/02/2026 at 18:00, 1 day 1 hour ago Covivio - Information on total number of voting rights and share capital
